Skip to main content
NIH funding notice RFA-RM-22-002

SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required)

Closed on April 1, 2022.

Posted
December 14, 2021
Close date
April 1, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,996,965 in first-year total cost, median $6,996,965.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMST-U (70)]1

Most frequent institutions

  1. UNIVERSITY OF MINNESOTA1
Competing awards under RFA-RM-22-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022REVEAL - Research Evaluating Vagal Excitation and Anatomical Linkages.1U54AT012307-01EBERLY, LYNN EIKRAMUDDIN, SAYEEDLIM, HUBERT HYUNGILMACEFIELD, VAUGHAN GARYNAHAS, ZIADOSBORN, JOHN WUNIVERSITY OF MINNESOTA, MN$6,996,965ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-RM-22-002: SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required) | ScienceDex | ConductScience